Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-09-09Clinical Trial Update: BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer [Phase 1]
A Phase 1 trial evaluating the combination of BMS-188797 with carboplatin in adults with advanced nonhematologic solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-06Clinical Trial Update: Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours [Phase 1]
Phase 1 safety study of CHR-2797 in patients with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer
Completed clinical trial update outlining nerve changes and neurotoxicity observed in adult cancer patients receiving chemotherapy or biolog…
-
CLINICAL_TRIALS trial_result · 2010-05-31Clinical Trial Update: Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan [Phase 1]
Phase 1 study update reporting safety and preliminary efficacy of patupilone in Japanese patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2010-05-20Clinical Trial Update: Phase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's Lymphomas [Phase 1]
A Phase I study of CEP-18770, a proteasome inhibitor, in patients with solid tumors and Non-Hodgkin lymphoma has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-05-04Clinical Trial Update: Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors [Phase 1]
Phase 1 dosimetry study of I-131-CLR1404 in patients with relapsed or refractory advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2010-05-03Clinical Trial Update: A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together [Phase 1]
Pfizer-sponsored Phase 1 trial completed to identify the best dosing combination of sunitinib (SU011248) and capecitabine in patients with s…
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced Cancer [Phase 1]
Phase 1 safety study evaluating oral TAK-593 in adults with nonhematologic advanced solid tumors; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies. [Phase 1]
Phase 1 study evaluating the safety, absorption, breakdown and elimination of R306465 in patients with advanced solid tumors; the trial has …
-
CLINICAL_TRIALS trial_result · 2010-04-26Clinical Trial Update: A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies. [Phase 1]
Phase 1 safety and dose-finding study of JNJ-26483327 in patients with advanced solid malignancies has been completed.
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-02) [Phase 1]
A Phase I study evaluating the safety and tolerability of EZN-2208 in patients with lymphoma or advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-05Clinical Trial Update: A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002) [Phase 1, Phase 2]
This trial update reports a rollover Phase 1/2 study evaluating long-term safety and continued benefit of irinotecan with or without carbopl…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: SU5416 and Paclitaxel in Treating Patients With Advanced Cancer [Phase 1]
Phase 1 trial update reporting on the combination of SU5416 with paclitaxel in adults with advanced solid tumors. The study has completed en…
-
CLINICAL_TRIALS trial_result · 2009-10-09Clinical Trial Update: A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01) [Phase 1]
A Phase I study evaluating the safety and tolerability of intravenous EZN-2208 in patients with advanced solid tumors or lymphoma has comple…
-
CLINICAL_TRIALS trial_result · 2009-08-26Clinical Trial Update: ARQ 197 in Subjects With Metastatic Solid Tumors [Phase 1]
A Phase 1 trial update for ARQ 197 (tivantinib) in patients with metastatic solid tumors; the study has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-20Clinical Trial Update: Open Label, Dose Escalation Phase I Study of AZD2281 [Phase 1]
This document summarizes an open-label, dose-escalation Phase I trial of AZD2281 (olaparib) in patients with advanced solid tumors, focusing…
-
CLINICAL_TRIALS trial_result · 2009-08-14Clinical Trial Update: Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction [Phase 1]
Pfizer-sponsored Phase 1 trial of irinotecan in patients with refractory solid tumors and liver dysfunction has completed, providing safety …
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors [Phase 1]
Phase 1 study update of cetuximab (Erbitux) in pediatric patients with refractory solid tumors; the trial completed and results were posted …
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 dose-escalation study of CX-3543 in patients with advanced solid tumors or lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
A Phase 1 dose-escalation study of Quarfloxin in patients with advanced solid tumors or lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Solid Tumor [Phase 1]
Phase 1 study evaluating Gimatecan in adults with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-30Clinical Trial Update: Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy [Phase 4]
Phase 4 study evaluating rasburicase for treatment or prevention of hyperuricemia associated with tumor lysis syndrome in patients with rela…
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors [Phase 1]
This is an update on a Phase 1 safety trial to determine the maximum tolerated dose of elesclomol sodium in patients with metastatic solid t…
-
CLINICAL_TRIALS trial_result · 2009-02-24Clinical Trial Update: CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of CT-322 in patients with advanced solid tumors and non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-28Clinical Trial Update: A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors [Phase 2]
Phase 2 pharmacokinetic study in children with recurrent solid tumors evaluating oral cyclophosphamide and topotecan.